1) Welcome to a tweetorial on optimizing the role of the pharmacist in managing cardiometabolic disease! Accredited for 0.50 credits by @academiccme: physicians, nurses, pharmacists! Expert faculty @SnayCardsPharmD pic.twitter.com/PmySBRzLUa
— cardio-met (@cardiomet_CE) April 27, 2021
3) First, a poll. The IOM estimates how many Americans are harmed by errors involving prescription medications each year?
— cardio-met (@cardiomet_CE) April 27, 2021
5) Now that we know how frequent medications errors occur, how commonly is the class of cardiovascular (CV) drugs associated with medication errors compared to other reported drug classes?
— cardio-met (@cardiomet_CE) April 27, 2021
7) . . . https://t.co/tlft8ZOEcr https://t.co/GELYE3J0yY
— cardio-met (@cardiomet_CE) April 27, 2021
9) How can pharmacists help in the care of patients with cardiometabolic disease? SO many ways! pic.twitter.com/ACkasGVnW9
— cardio-met (@cardiomet_CE) April 27, 2021
11) 61-year-old male with a history of HTN, Dyslipidemia, Diabetes and of course he’s a 20 pack-year smoker.
— cardio-met (@cardiomet_CE) April 27, 2021
13) Current meds: Lisinopril 10 mg daily, Atorvastatin 20 mg daily, Metformin 1000 mg BID
— cardio-met (@cardiomet_CE) April 27, 2021
15) Return tomorrow for more on this case and more reminders of the VITAL role pharmacists play in improving the health outcomes of patients with cardiometabolic disease! @UK_COP @UGAPharmacy @UAZPharmacy @USFCOP @uofupharmacy @unmcop @ISUPharmacy @neomedcop @KCHPharmacy
— cardio-met (@cardiomet_CE) April 27, 2021
17) Meta-analyses evaluating the role of the pharmacist in BP management reveal improvement in SBP in the 6 – 8 mm Hg range. How? (ref: Santschi V et al. Arch Intern Med 2011;171:1441-53: https://t.co/h9837Q6YXV and Diabetes Care 2012;35:2706-17: https://t.co/eaA7xo8Bhw )
— cardio-met (@cardiomet_CE) April 28, 2021
19) One more point – the impact of a pharmacist is not unique to one single practice area. Pharmacists practicing in clinics, in-hospital and in community pharmacies all improve BP when involved in patient care.
— cardio-met (@cardiomet_CE) April 28, 2021
21) Pts enrolled were similar to our patient – high risk for CVD from: diabetes or GFR < 60 mL/min or polyvascular disease, Framingham risk > 20%, current smoker, + ≥ 1 uncontrolled risk factor (BP, LDL, A1c > 7%)
— cardio-met (@cardiomet_CE) April 28, 2021
23) The primary outcome was the difference in change in estimated cardiovascular risk between intervention and usual care groups at 3 months. How did pharmacist intervention impact cardiometabolic risk at 3 months?
— cardio-met (@cardiomet_CE) April 28, 2021
25) Let’s circle back to our patient. His A1c is 7.8% only taking metformin. If you wanted to initiate an #SGLT2 Inhibitor, pharmacists can assist in many ways: which agent is most affordable, how to dose for renal function, what to monitor pic.twitter.com/fUdm0LkQKV
— cardio-met (@cardiomet_CE) April 28, 2021
27) Perhaps instead the patient is initiating #insulin. Need someone to teach our patient how/where to inject? Pharmacists will gladly educate him. Best injection sites: abdomen, thigh, upper arm. Don’t forget to rotate sites! pic.twitter.com/V5gJfICVcB
— cardio-met (@cardiomet_CE) April 28, 2021
29) Before we conclude, let’s review how pharmacists can optimize the care of patients with cardiometabolic risk:
— cardio-met (@cardiomet_CE) April 28, 2021
•Reduce medication errors
•Improve CV risk-factor control
•Enhance knowledge, adherence and QOL
30) So you made it! Free CE/CME! Pharmacists, physicians, nurses: go to https://t.co/G41uROW0yU and claim your credit! I am @SnayCardsPharmD. Follow @cardiomet_CE for more tweetorials! #medtwittter #cardiotwitter #pharmacisttwitter #FOAMed
— cardio-met (@cardiomet_CE) April 28, 2021